"Attention deficit disorder (ADD) psychosis" merits delineation as a separate entity. It constitutes the end result of the effects of a certain particular neurological deficit (ADD) on personality organization. It is my belief that about 10 percent of psychoses currently diagnosed most often schizophrenic and sometimes affective psychosis must best be considered a separate organic psychosis, i.e., an ADD psychosis. This ADD psychosis, then, is not merely a subgroup of schizophrenia, as I once thought. It merits a separate designation because its etiology, pathogenesis, and life history are different from those of the schizophrenic syndrome. The family histories are also different, as are the psychological findings. The treatment response is so different that it merits urgent consideration. Prognosis, both short range and long range, also seems different from those of the other psychoses.
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The concept of attention deficit disorder (ADD), previously called minimal brain dysfunction (MBD), has had a complex and circuitous history. A number of terms referring to some aspects of this particular syndrome, such as hyperactivity and dyslexia, were, for the first time, subsumed under the collective term "MBD" in a conference at the National Institute of Mental Health in 1964 (Clement 1966 . However, the concept was then strictly related to children and remained that way, with practically no reference to its presence in adults, until 1978. Several of us (Bellak 1979a) agreed then that many of the symptoms of ADD continued to be present in adults, causing, instead of school problems, more phase-specific problems such as frequent job change, asocial behavior, problems of disorientation in everyday life, and pathology of personality of various types, operationally definable in terms of 12 ego functions. Previously, I had suggested that ADD might produce a subgroup of schizophrenia (Bellak 1979b) . I now believe that a condition called "ADD psychosis" merits a separate designation because its intragroup similarities are great, as well as the intergroup differences (see table 1 ).
With regard to the differentiation of ADD psychosis from affective disorders, manic psychosis is almost exclusively of concern as only mania seems to present itself as a problem in differential diagnosis (see table 2 ).
Therapeutics
Since the purpose of this article is to make a potentially useful hypothesis publicly available, it is desirable to discuss the therapeutic aspects. In my experience, it is best to start ADD patients with 10 mg of imipramine h.s. Very often this will, within hours or less, produce some tranquility in tense patients, a better attention span, some decrease in dyslexic difficulties, and a decrease in overactivity, delusions, and impulsivity.
If 10 mg does not accomplish the above, the dosage may be increased up to 30 mg. Some patients do well on this large a dose for about 2 weeks and then show their previous symptoms again. In that case, it has been useful, in my experience, to decrease their dosage again in 5-mg steps until some optimal level of In female patients with increased tension and other exacerbation premenstrually, diphenylhydantoin, 100 mg h.s., for the days preceding menses is ordinarily very effective. Occasionally 10 mg of diazepam is a necessary addition to any of the above drugs for some tension states. Neuroleptics, however, are almost always contraindicated, as they produce feelings of depersonalization, confusion, and even agitation in patients with ADD psychosis. Haloperidol, usually 2 mg h.s., is the only exception to that rule.
Implications for Research
In order to establish the validity of the above hypothesis, controlled experimental studies are necessary. These studies would best be carried out, at least eventually, in several cooperating institutions. It is entirely possible, and even likely, that the incidence of ADD in the general population, and specifically in the schizophrenic population, may vary with socioeconomic status. It is probable that ADD has multiple etiologic and pathogenic roots and that some of these might relate to nutrition, general quality of infant care, and specific quality of medical care. These are the factors sensitive More females than males so afflicted to the Hollingshead Index. Genetic 'factors are more likely to be evenly distributed.
For epidemiological reasons, a multihospital study will also be useful. It has been reported, for instance (Bloomingdale 1984) , that the highest incidence of ADD occurred in an area abutting the busiest thoroughfare in Ottawa. This finding suggests that toxic exhaust fumes may play a role in the incidence of ADD. A hospital that includes such a traffic artery in its catchment area is likely to have a higher population with ADD psychosis than would one in a rural area.
For a basic research model, it will be necessary to have a large group of patients diagnosed schizophrenic by DSM-III criteria (American Psychiatric Association 1980) by two independently rating clinicians. These patients would be screened again for the differential diagnostic criteria mentioned for ADD, i.e., symptomatology, neuropsychological and neurological factors, as well as personal and family history. If my hypothesis is valid, the above procedure should filter out about 10 percent of patients who fulfill the criteria for ADD psychosis.
An experimental design in which drug treatment is used as a therapeutic test is then indicated, to establish predictive validation of ADD psychosis as a diagnostic entity separate from schizophrenia. One group of patients diagnosed schizophrenic without ADD criteria would be compared to a matched group with ADD. These groups would be put on chlorpromazine and imipramine, respectively. There are merits to either a crossover or a parallel design, with appropriate allowance for washout and placebo effects.
Either of these two designs would (Marcus et al. 1985) provided the first major data with regard to the long-term stability of neurological soft signs, consistent with the hypothesis advanced here. This study, as well as the other group of studies reported in the same issue of the Schizophrenia Bulletin (Vol. 11, No. 1, 1985) , is also consonant with the hypothesis of an ADD psychosis, though not confirming it. The followup in this group involves children and adolescents who are the offspring of schizophrenic patients. Apparently, the parents themselves were not studied for soft signs. A further investigation of the incidence of ADD in the parents of these children with soft signs might lend support to the familial nature of this syndrome. If parents of children with soft signs, diagnosed schizophrenic, should turn out to have a higher incidence of ADD by my criteria, a therapeutic test, as mentioned above, would be very illuminating. Bloomingdale (1984) has concluded: ADD remains an enigma: A complex of symptoms that is as fascinating as any detective story (to those who accept its existence, at least). We may conclude where we started: Is ADD a syndrome with a known etiology, known onset, known course, and known treatment? Of course, at this time it is not. But this is true of all psychiatric "diagnoses." [p. 183] The same can be said for ADD psychosis, but the above research approaches would be a positive step that may prove to be of great clinical usefulness.
